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Developing organs acquire a specific three-dimensional form that ensures their normal function. Cardiac function, for
example, depends upon properly shaped chambers that emerge from a primitive heart tube. The cellular mechanisms
that control chamber shape are not yet understood. Here, we demonstrate that chamber morphology develops via
changes in cell morphology, and we determine key regulatory influences on this process. Focusing on the development
of the ventricular chamber in zebrafish, we show that cardiomyocyte cell shape changes underlie the formation of
characteristic chamber curvatures. In particular, cardiomyocyte elongation occurs within a confined area that forms the
ventricular outer curvature. Because cardiac contractility and blood flow begin before chambers emerge, cardiac
function has the potential to influence chamber curvature formation. Employing zebrafish mutants with functional
deficiencies, we find that blood flow and contractility independently regulate cell shape changes in the emerging
ventricle. Reduction of circulation limits the extent of cardiomyocyte elongation; in contrast, disruption of sarcomere
formation releases limitations on cardiomyocyte dimensions. Thus, the acquisition of normal cardiomyocyte
morphology requires a balance between extrinsic and intrinsic physical forces. Together, these data establish
regionally confined cell shape change as a cellular mechanism for chamber emergence and as a link in the relationship
between form and function during organ morphogenesis.
Citation: Auman HJ, Coleman H, Riley HE, Olale F, Tsai HJ, et al. (2007) Functional modulation of cardiac form through regionally confined cell shape changes. PLoS Biol 5(3):
e53. doi:10.1371/journal.pbio.0050053
Introduction
Embryonic organs acquire a characteristic size and shape
during their development. Cell division and cell growth
control are known to inﬂuence organ size (reviewed in [1–4]).
Organ shape, on the other hand, is not simply a consequence
of accumulated cell number and mass; organ shaping is also a
physical process, during which tissues are pressed, pulled, and
moved. Therefore, the acquisition of an organ’s three-
dimensional form may involve an important interplay of cell
shape, cellular organization, and the physical forces that
impact them [5,6].
The particular shape of the embryonic vertebrate heart is
critical for its normal function: the heart is composed of a
series of chambers that rhythmically drive circulation, and the
morphology of each chamber contributes to its functional
capacity. The primitive heart begins as a simple linear tube,
and this structure gradually transforms into two discrete
chambers, a ventricle and an atrium (Figure 1A); in higher
vertebrates, septation later divides these two chambers into
four [7,8]. Transformation of the heart tube into the
chambered heart requires simultaneous processes known as
looping and ballooning. Looping involves bending and twisting
of the heart tube in order to create asymmetry of the
chambers relative to the embryonic left–right axis [7,9].
Ballooning involves the emergence of localized bulges on
the tubular wall that expand to create the shapes of the
cardiac chambers [8,10]. Each expanded chamber assumes a
bean-like morphology, featuring two distinctly curved surfa-
ces: a greater, convex curvature called the outer curvature
(OC) and a lesser, concave curvature called the inner
curvature (IC) (Figure 1A) [10–12]. In addition to their
morphological differences, the OC and IC can be distin-
guished by the expression of curvature-speciﬁc genes (e.g., the
OC gene natriuretic peptide precursor a [nppa]) and different
physiological properties (e.g., faster conduction velocity at the
OC) [10,12–14].
Formation of chamber curvatures is a critical step in the
development of a functionally mature heart, yet little is
understood about the mechanisms that establish chamber
shape. Curvature dimensions could be the product of
differential patterns of cell proliferation, cellular organiza-
tion, or cell shape changes. Each of these mechanisms has
been suggested to contribute to cardiac looping [15–20].
Previous studies indicate the existence of differential
proliferation rates within areas of the looped chick heart
[21]. However, studies in mouse argue against the notion that
proliferative centers govern cardiac morphogenesis and
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PLoS BIOLOGYinstead favor patterns of oriented cell division as a
mechanism for generating chamber form [22]. Other studies
in the chick have found that apical cell surfaces change
differentially during looping [17] and that cell volumes
enlarge differentially during ballooning [23], inspiring mod-
els in which changes in cell morphology drive the generation
of cardiac left–right asymmetry [24] and chamber expansion
[23]. It remains unclear which types of cellular changes
underlie chamber curvature formation and how such changes
are triggered.
Since cardiac contraction and blood ﬂow begin at linear
heart tube stages, chamber emergence and additional steps of
cardiac morphogenesis take place while organ function is
underway. Thus, biomechanical consequences of cardiac
function, such as the ﬂuid forces generated by circulating
blood, have the potential to inﬂuence cardiac form (reviewed
in [25]). Indeed, blockage of blood ﬂow [26] or disruption of
cardiac contractility [27] inhibits the formation of endocar-
dial cushions at the boundary between the ventricle and the
atrium, implicating biomechanical forces in the initiation of
atrioventricular valve formation. Less is known about the
impact of cardiac function on chamber curvature formation,
although prior studies have indicated that chamber morphol-
ogy is vulnerable to changes in functional parameters. For
example, zebraﬁsh and mouse mutants lacking atrial con-
tractility also exhibit abnormal ventricular morphology,
suggesting that blood ﬂow through the ventricle somehow
inﬂuences its shape and size [28,29]. However, the precise
mechanisms by which functional inputs contribute to the
control of chamber emergence are not yet understood.
Here, we address the open question of which cellular
mechanisms underlie the formation of chamber curvatures
and test their dependence upon functional inﬂuences. Taking
advantage of the opportunities for high-resolution imaging of
the developing zebraﬁsh heart, we identify regionally conﬁned
cell shape changes as a key parameter in shaping chamber
curvatures. Using zebraﬁsh mutations that disrupt aspects of
cardiac function, we determine that blood ﬂow and contrac-
tility independently impact cell shape changes in the emerg-
ing ventricle. Thus, the acquisition of chamber shape via cell
shape changes requires a balance between extrinsic and
intrinsic biomechanical forces. Together, our data provide a
Figure 1. nppa Expression Distinguishes the OC and IC of the Zebrafish Ventricle
(A) Cartoon of the zebrafish LHT (24–28 hpf) and expanded chamber (48–58 hpf) stages. The expanded ventricle (V) and atrium (A) each exhibit an OC
and IC, as outlined on the ventricle.
(B and F) Live images of embryos expressing Tg(cmlc2:egfp) in the LHT (dorsal view) and in the expanded chambers (frontal view). The arterial and
venous halves of the LHT will form the ventricle and atrium, respectively [51]. Specific regions of the LHT will expand to create the OC of the ventricle
([B] arrow) and the OC of the atrium ([B] arrowhead).
(C–E and G–I) Whole-mount in situ hybridization comparing expression of the myocardial gene cardiac myosin light chain 2 (cmlc2) with expression of
nppa at LHT ([C–E] dorsal view) and expanded chamber ([G–I] frontal view) stages. (E and I) Fluorescent in situ hybridization depicts cmlc2 expression in
green and nppa expression in red. In the LHT, nppa expression is regionally restricted to the future OC of the ventricle ([C–E] arrow); at this stage, faint
expression is also detectable in the future OC of the atrium ([E] arrowhead). In the expanded chambers, nppa is expressed in the OC, but absent from
the IC and atrioventricular canal (G–I).
doi:10.1371/journal.pbio.0050053.g001
Author Summary
As organs develop, they acquire a characteristic shape; the factors
governing this complex process, however, are not understood.
Shape may be sculpted by cell movement, cell division, or changes
in cell size and shape, all of which can be influenced by the local
environment. Here we investigate heart formation to understand
how organs develop. The heart appears as a simple tube early in
development; later, the tube walls bulge outward to form the
cardiac chambers. Using transgenic zebrafish in which we can watch
individual cardiac cells, we found that cells change size and shape,
enlarging and elongating to form the bulges in the heart tube and
eventually the chambers. Since the heart is beating as it develops,
we asked whether cardiac function influences cell shape. Using
zebrafish mutants with functional defects, we found that both blood
flow and cardiac contractility influence cardiac cell shape. We
propose that a balance of the cell’s internal forces (through
contractility) with external forces (such as blood flow) is necessary
to create the cell shapes that generate chamber curvatures.
Disruption of this balance may underlie the aberrations observed
in some types of heart disease.
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Modulation of Cardiomyocyte Shapemodel for the cellular mechanisms by which function can
inﬂuence form during the deﬁnition of organ shape.
Results
nppa Expression Distinguishes Chamber Curvatures in
Zebrafish
Chamber emergence occurs rapidly in the zebraﬁsh
embryo: the linear heart tube (LHT), which contracts and
drives circulation by 24 h post-fertilization (hpf), transforms
into two morphologically evident chambers, the ventricle and
the atrium, by 48 hpf (Figure 1) [30]. As in other vertebrate
hearts [10–12], each chamber is bean-shaped, with a distinct
OC and IC (Figure 1A). In chick and mouse, expression of the
natriuretic peptide precursor a (nppa) gene, also known as atrial
natriuretic factor (anf), is restricted to the OC of the ventricle
and atrium [10,31]. Similarly, we ﬁnd that zebraﬁsh nppa [28]
marks OC myocardium as chambers emerge. Expression of
nppa is ﬁrst detectable by 24–28 hpf in a domain on the right
side of the ventricular portion of the LHT (Figure 1C–1E,
arrow) and a domain on the left side of the atrial portion of
the LHT (Figure 1E, arrowhead). These domains are
positioned to become the future ventricular and atrial OCs.
As ballooning proceeds, nppa expression remains regionally
restricted, being localized to the OC myocardium of both
chambers while absent from the IC and atrioventricular canal
regions (Figure 1G–1I). Thus, in parallel to the process
observed in higher vertebrates, chamber emergence in
Figure 2. Regionally Confined Cell Shape Changes Accompany Chamber Emergence
(A and B) Phalloidin staining (red) of wild-type hearts expressing Tg(cmlc2:egfp). Insets show representative cell shapes filled in white.
(C and D) Bar graphs depict surface area and circularity measurements of LHT, IC, and OC cells. Bar height indicates the mean value of a dataset, and
error bars indicate standard error. An asterisk indicates statistically significant differences compared to LHT data (p , 0.0001). See Materials and
Methods for details of morphometric analyses. (C) Surface area measurements in fixed samples demonstrate that IC and OC cells are significantly larger
than LHT cells. (D) Cell shape assessments in fixed samples demonstrate that OC cells are significantly elongated relative to the more circular LHT andI C
cells.
(E–L) Confocal projections of live Tg(cmlc2:egfp)-expressing hearts that exhibit mosaic expression of Tg(cmlc2:dsredt4). Arrows point to representative
cells expressing both dsredt4 and egfp. Three-dimensional assessment of cell morphologies in live embryos confirms that LHT (E and I) and IC (H and L)
cells are relatively cuboidal, whereas OC cells are flattened and elongated (F, G, J, and K). OC cells are typically oriented with their long axes
perpendicular to the arterial–venous axis (F and J), although some examples do not exhibit obvious orientation (G and K).
doi:10.1371/journal.pbio.0050053.g002
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Modulation of Cardiomyocyte Shapezebraﬁsh features the development of morphological and
molecular differences between OC and IC myocardium.
Regionally Confined Cell Shape Changes Accompany
Chamber Emergence
Despite the rapid emergence of the OC and IC during
zebraﬁsh heart development, it is not known which cellular
mechanisms are responsible for establishing chamber curva-
tures during this time frame. We chose to test the hypothesis
that the morphologically and molecularly distinct OC and IC
regions also possess distinct cellular characteristics. Analyses
of chick hearts have indicated that OC cells increase their
apical surface area and volume during looping and balloon-
ing [17,23]. To determine whether cell morphology changes
contribute to the formation of chamber curvatures in
zebraﬁsh, we assessed the shape and size of cardiomyocytes
as chambers emerge, focusing our analysis on the ventricle
(Figure 2). We examined cell shape and surface area by using
phalloidin to outline cells in embryos carrying the transgene
Tg(cmlc2:egfp), which is expressed throughout the myocardium
[32] (Figure 2A and 2B). Additionally, in order to view
multiple cell surfaces and to examine cell morphology
without ﬁxation, we imaged live cells expressing
Tg(cmlc2:dsredt4) mosaically within Tg(cmlc2:egfp)-expressing
hearts (Figure 2E–2L; see Materials and Methods).
First, we examined cardiomyocyte morphology within the
ventricular portion of the LHT (24–28 hpf; Figure 2A, 2C–2E,
and 2I). Surface area measurements and shape assessments
demonstrate that all cells in this region exhibit small and
rounded morphologies (Figure 2A, 2C–2E, and 2I). Thus, even
though nppa expression within the LHT anticipates formation
of the OC (Figure 1D), cell morphologies are relatively
uniform among the ventricular precursors at this stage. As
development proceeds, ventricular cells increase their surface
area (Figure 2C). Notably, however, only the cells in the OC of
Figure 3. Mutation of wea and haf Cause Chamber-Specific Contractility Defects
Analysis of wea, haf, and wea;haf double mutants at 48 hpf reveals abnormal ventricular morphology and chamber-specific sarcomere deficiencies.
hafsk24 and weam58 are recessive mutations that independently segregate; intercrosses of fish doubly heterozygous for wea and haf produce a 9:3:3:1
ratio of wild type:wea:haf:wea;haf.
(A–D) Lateral views of live embryos, anterior to the top, ventricular plane of focus. (A) The wild-type (wt) ventricle possesses distinct concave
(arrowhead) and convex (arrow) curvatures. (B) In contrast, the wea ventricle appears small, with less-pronounced curvatures. (C) The haf ventricle
appears large and distended, with a notable separation between the myocardium and endocardium. (D) The wea;haf ventricle is small, with relatively
spherical contours.
(E–L) Whole-mount immunofluorescence detecting tropomyosin (CH1; green) and sarcomeric myosin heavy chain (MF20; red). Lateral views, ventricle to
the left. Tropomyosin is present in all cardiomyocytes (E–H). In contrast, myosin heavy chain appears absent from the wea atrium (J), haf ventricle (K),
and both chambers of the wea;haf heart (L).
(M–T) Ultrastructural analysis of cardiomyocytes by transmission electron microscopy. Normal myofibril arrays (arrows) are present in wt chambers( M
and Q), in the wea ventricle (N), and in the haf atrium (S). Organized myofibril arrays are absent from the wea atrium (R), the haf ventricle (O), and both
chambers of the wea;haf heart (P and T).
doi:10.1371/journal.pbio.0050053.g003
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Modulation of Cardiomyocyte Shapethe expanded ventricle (48–58 hpf) signiﬁcantly change their
shape (Figure 2D). OC cells become ﬂattened and elongated
(Figure 2B, 2D, 2F, 2G, 2J, and 2K), and they are typically
aligned with one another and oriented with their long axes
perpendicular to the arterial–venous axis (Figure 2B, 2F, and
2J; Video S1), although occasionally they lack an obvious
orientation (Figure 2B, 2G, and 2K; Video S2). Meanwhile, IC
cells fail to ﬂatten or elongate and instead maintain a
cuboidal morphology (Figure 2B, 2D, 2H, and 2L; Video S3).
We note that elongation is already apparent in some cells
positioned to become OC at an intermediate stage of
chamber emergence (36 hpf; unpublished data), suggesting
that elongation of OC cells occurs gradually, concurrent with
the gradual process of chamber expansion. We therefore
propose that regionally conﬁned cell shape changes underlie
the acquisition of chamber morphology: the elongation and
orientation of OC cells, coupled with the maintenance of
cuboidal shape by IC cells, could account for the character-
istic curvatures of the expanded ventricle.
Blood Flow Promotes Ventricular Cell Enlargement and
Elongation
Because chamber emergence takes place following the
onset of embryonic circulation, the physical forces inherent
to cardiac function could inﬂuence the cell shape changes
that accompany curvature formation. For example, normal
blood ﬂow, which creates changes in pressure and shear
forces, has the potential to contribute to the induction of
cellular enlargement and elongation at the OC. The zebraﬁsh
mutation weak atrium (wea) causes a phenotype appropriate
for testing this hypothesis (Figure 3). The wea locus encodes
atrial myosin heavy chain (amhc, also known as myh6), an atrium-
speciﬁc myosin isoform [28]. Thus, wea mutants lack atrial
sarcomeres, resulting in impaired atrial function and
decreased blood ﬂow through the ventricle compared with
wild type ([28]; Figure 3M, 3N, 3Q, and 3R, and Videos S4 and
S5). Although amhc is not expressed in the ventricle,
ventricular shape and size are altered in wea mutants
compared with wild type ([28], Figure 3A, 3B, 3E, 3F, 3I, and
3J). The wea mutant ventricle is small and dysmorphic, with
less-pronounced curvatures than in the OC and IC of the
wild-type ventricle. This secondary consequence of atrial
dysfunction presumably indicates an impact of blood ﬂow on
ventricular morphology [28]. Because the cardiac cell number
in the wea mutant ventricle is normal [28], the ventricle’s
abnormal morphology does not reﬂect a defect in cardio-
myocyte proliferation. Instead, its aberrant curvatures could
be the result of aberrant cell shapes or cellular organization.
To investigate this possibility, we examined cardiomyocyte
morphologies in the wea mutant ventricle (Figure 4).
In the wea LHT, cell shapes are uniform, round, and
indistinguishable from those of wild type, although measure-
Figure 4. Cardiomyocytes in the wea Mutant Ventricle Retain Small Surface Areas and Fail to Elongate Normally
(A–D) Phalloidin staining (red) of wild-type (wt) and wea mutant hearts expressing Tg(cmlc2:egfp) at LHT (A and B) and expanded chamber (C and D)
stages.
(E) Bar graphs depict surface area and circularity measurements, as in Figure 2. An asterisk indicates statistically significant differences compared to wt
data (p , 0.0001). Since chamber curvatures are less distinct in wea mutants than they are in wt embryos, OC and IC data are pooled for comparison of
cell size and shape at expanded chamber stages. Analysis of fixed samples demonstrates that wea cell surfaces are significantly smaller and more
circular at chamber stages in comparison to wt. The trend toward smaller cell size in wea is also apparent at LHT stages (p , 0.05).
(F–H) Confocal projections of live hearts, as in Figure 2, confirm the contrast between cell morphologies in wt and wea mutant ventricles. The wt OC
typically contains elongated cells ([F] arrows), whereas wea OC cells have a smaller and less spread-out appearance, even when elongated ([G] arrow),
and are frequently cuboidal ([G and H] arrowheads). Size bar represents 20 lm.
doi:10.1371/journal.pbio.0050053.g004
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Modulation of Cardiomyocyte Shapements of surface area suggest a trend toward smaller cell size
(Figure 4A, 4B, and 4E). By the time of chamber emergence,
the surface area of individual cells throughout the ventricle is
s i g n i ﬁ c a n t l ys m a l l e rt h a ni nw i l dt y p e( F i g u r e4 C – 4 E ) .
Although elongated cells can be found in the wea OC, those
cells tend to be less elongated than cells in the wild-type OC
(Figure 4C–4H). In addition, cuboidal cell morphologies,
normally conﬁned to the IC, are frequently found in the wea
OC (Figure 4G and 4H). The persistence of small, cuboidal
cells in the wea ventricle does not reﬂect a simple devel-
opmental delay, because we detect similar cell morphologies
in wea mutants at 72 hpf (H. J. Auman and D. Yelon,
unpublished data). Additionally, treatment with 5 mM 2,3-
butanedione monoxime (BDM), another method for reducing
blood ﬂow in zebraﬁsh embryos [27], has an effect on
ventricular cardiomyocyte morphology similar to that ob-
served in wea mutants: at 48–52 hpf, BDM-treated ventricular
cells are smaller (83 6 2 lm
2 surface area) and less elongated
(0.82 6 0.01 circularity) than wild-type ventricular cells
(Figure 4E; 110 6 2 lm
2 surface area, 0.77 6 0.01 circularity;
both signiﬁcantly different from BDM-treated values, p ,
0.0001). The reduced degree of elongation observed in the
wea OC correlates with a reduction in nppa expression at this
location (Figure 5). Regionalized nppa expression initiates
normally in the wea LHT (Figure 5A, 5B, 5E, and 5F), but, by
52 hpf, ventricular nppa expression is weak and occupies a
smaller proportion of the chamber in comparison to wild-
type (Figure 5I, 5J, 5M, and 5N). Together, these data suggest
that normal blood ﬂow is needed to promote the cell
enlargement, cell elongation, and regionalized gene expres-
sion that accompany chamber curvature formation.
Contractility Restricts Ventricular Cell Size and Elongation
As blood ﬂow promotes cell enlargement, we hypothesized
that an opposing mechanism might restrict or moderate cell
size. We reasoned that a good candidate for such resistance
would be a feature intrinsic to the myocardial cell, such as its
contractility. To test this idea, we utilized a mutation in the
zebraﬁsh ventricular myosin heavy chain gene (vmhc, also known
as myh7) that blocks contractility in ventricular cardiomyo-
cytes (Figure 6). The ventricle-speciﬁc expression of vmhc
complements the atrium-speciﬁc expression of amhc ([28,33]
and Figure 6A and 6B). The half-hearted (haf) mutation (see
Figure 5. Regionalization of nppa Expression in wea, haf, and wea;haf Mutants Is Normal at LHT Stages but Abnormal at Expanded Chamber Stages
Whole-mount in situ hybridization of nppa (A–D and I–L) compared to cmlc2 (E–H and M–P).
(A–H) Dorsal views, ventricle to the top, at LHT stages. (A, B, E, and F) are 28 hpf; (C, D, G, and H) are 30 hpf. Although initiation of nppa expression is
delayed in haf (C) and wea;haf (D) mutants, the nppa expression domain is normal in the wea (B), haf (C), and wea;haf (D) LHT.
(I–P) Frontal views, ventricle to the left, at expanded chamber stages (52 hpf). (J) Regionalized nppa expression is not maintained in the wea mutant
ventricle; instead, nppa expression in the wea ventricle is fainter and in a smaller domain than in wild type (wt) (I). (K) In the haf mutant ventricle, intense
nppa expression is found throughout the chamber, rather than being restricted to the OC. (L) The wea;haf double mutant ventricle exhibits weak and
diffuse nppa expression.
doi:10.1371/journal.pbio.0050053.g005
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Modulation of Cardiomyocyte ShapeMaterials and Methods) creates a premature stop codon in
vmhc that is predicted to result in a truncated and non-
functional Vmhc protein (Figure 6C). As a result, haf mutants
lack ventricular contractility and provide a chamber-speciﬁc
functional complement to wea mutants (Figure 3O and 3S;
Video S6).
In contrast to the small ventricle of wea mutants, the haf
mutant ventricle is large and distended, with abnormally
spherical contours (Figure 3C). As for wea mutants, we found
that cardiac cell number in haf mutants is normal (at 48 hpf,
231 6 3 cells in wild type vs. 229 6 13 in haf, n¼4), suggesting
that aberrant cell shapes, rather than aberrant proliferation,
might underlie the development of abnormal ventricular
curvatures in haf. Indeed, examination of cell morphology in
the haf ventricle revealed a signiﬁcant increase in cell surface
area, which is already apparent in the LHT and becomes
more pronounced during chamber emergence (Figure 7A–
7E). Many cells within the expanded haf ventricle are also
highly elongated (Figure 7C–7G), although not all are
elongated to the same extent (Figure 7H). As in wild type,
the orientation of elongated cells in haf is typically perpen-
dicular to the arterial–venous axis. However, rather than
being restricted to the OC, elongated cells are often found
throughout the chamber. The overextension and overrepre-
sentation of elongated cells in the haf ventricle correlate with
the increased and widespread expression of nppa throughout
the chamber (Figure 5K). In contrast, nppa expression is
correctly regionalized in the haf LHT, despite a slight delay in
initiation of expression (Figure 5C). Overall, these data
indicate that Vmhc function is required to restrict cell size,
to limit the extent of cellular elongation, and to conﬁne the
distribution of elongated cell types during chamber curvature
formation.
Intrinsic Contractility Independently Regulates
Cardiomyocyte Morphology
Our analysis of the haf mutant phenotype indicates that
ventricular cell shapes are signiﬁcantly affected by the loss of
Vmhc function, raising the possibility that cardiomyocyte
contractility directly inﬂuences cardiomyocyte morphology.
However, it is also possible that the particular hemodynamic
environment in haf mutants could have an indirect effect on
ventricular cell shape. Although the haf ventricle is non-
contractile, the haf atrium contracts normally (Video S6). As a
result, blood ﬁlls the haf ventricle without subsequent
ventricular response. Thus, haf ventricular cells are likely
subjected to an elevation in preload that could potentially
lead to secondary effects on cell shape. We therefore wished
to uncouple the inﬂuences of blood ﬂow and contractility in
the establishment of cell shapes, and proceeded to test
whether the morphology of a noncontractile ventricular cell
changes when placed in different hemodynamic conditions
(Figure 8).
The wea;haf double mutant, which lacks both atrial and
ventricular contractility (Figure 3L, 3P, and 3T; Video S7),
enabled us to test the role of vmhc in the acquisition of
ventricular cell shape without the complicating factor of
atrial contraction and elevated preload. Although the wea;haf
ventricle is typically not as distended as the haf ventricle, both
ventricles have a relatively spherical appearance (Figure 3C
and 3D). Cell shape and size are normal in the wea;haf LHT;
Figure 6. haf
sk24 Is a Strong Loss of Function Allele of vmhc, a Ventricle-Specific Myosin Heavy Chain Gene with Expression Complementary to amhc
(A and B) Fluorescent in situ hybridization for vmhc (green) and amhc (red) in wild-type (wt) embryos at LHT ([A] 26 hpf, dorsal view) and expanded
chamber ([B] 48 hpf, frontal view) stages. At all stages examined, vmhc is expressed in the ventricular myocardium [51]. In contrast, amhc expression is
restricted to the atrial myocardium [28].
(C) Comparison of vmhc coding sequence in wt and haf
sk24 embryos reveals a C to T transition at position 3,094 that results in a premature stop codon
in haf
sk24.
(D and E) Whole-mount in situ hybridization depicts frontal view of vmhc expression in wt and haf at 48 hpf. vmhc expression is dramatically reduced in
the haf mutant ventricle.
doi:10.1371/journal.pbio.0050053.g006
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Modulation of Cardiomyocyte Shapethe double mutants exhibit neither the large cells of the haf
LHT nor the trend toward small cells seen in the wea LHT
(Figure 8A, 8B, and 8E). However, cells in the wea;haf
expanded ventricle are clearly abnormal: they are irregularly
shaped and lack apparent alignment, consistent orientation,
or regional organization (Figure 8C and 8D). The lack of a
particular area of cellular elongation in the wea;haf ventricle
correlates with its diffuse, weak nppa expression (Figure 5I
and 5L). Strikingly, unlike wea cells, which maintain small size
and cuboidal morphology within the expanded chamber,
wea;haf cells do enlarge and elongate, despite an absence of
blood ﬂow. Indeed, although they exhibit irregular morphol-
ogies, wea;haf cells exhibit an average surface area and
circularity similar to that of wild-type cells (Figure 8E).
Therefore, wea;haf ventricular cells seem to lack an intrinsic
mechanism for maintenance of cell morphology.
To test this idea further, we challenged the shape of haf
cells by placing them into a hemodynamic environment in
which they would be subjected to normal ﬂow, as is found
within the wild-type ventricle. We transplanted haf mutant
cells into wild-type hosts at midblastula stages and analyzed
the morphology of resultant haf ventricular clones in the
expanded chamber. In this context, haf cells adopt an entirely
different and unusual morphology: whether in the OC or IC,
the noncontractile haf donor cells round up and extrude from
the contractile ventricular wall (Figure 8H and 8K). This
protrusion phenotype, seen in four out of four embryos, was
never observed when wild-type (n . 10 embryos) or wea (n .
12 embryos) cells were transplanted in control experiments
(Figure 8F, 8G, 8I, and 8J). These results demonstrate that
Vmhc is required cell-autonomously for maintenance of
cardiomyocyte morphology and chamber wall integrity.
Additionally, our haf, wea;haf, and transplantation data argue
that the particular irregular shape adopted by a cell lacking
Vmhc depends upon the contractility of its neighbors and the
nature of its hemodynamic environment. Together, our data
indicate that maintenance of appropriate cardiomyocyte size
and shape requires cell-autonomous traits that are dependent
on contractility and independent of the inﬂuence of blood
ﬂow.
Discussion
Cell Shape Changes Underlying Chamber Emergence
Require a Balance of Biomechanical Forces
Together, our analyses provide a new model for the cellular
processes creating chamber shape. During ventricular cham-
ber emergence, regionally conﬁned cell shape changes
correlate with the locations of curvature formation. We
therefore propose that cardiomyocyte elongation plays a
substantial role in creating the characteristic convex shape of
the OC; on the opposing side of the chamber, maintenance of
cuboidal cardiomyocyte morphology contributes to creating
the concave IC. Blood ﬂow through the developing ventricle
promotes cardiomyocyte elongation and thereby encourages
establishment of the OC. The limits of cardiomyocyte
elongation are constrained by the cell’s intrinsic contractility,
Figure 7. Cardiomyocyte Surfaces throughout the haf Ventricle Become Excessively Enlarged and Elongated
(A–D) Phalloidin staining (red) of wt and haf mutant hearts expressing Tg(cmlc2:egfp) at LHT (A and B) and expanded chamber (C and D) stages.
(E) Bar graphs depict surface area and circularity measurements, as in Figure 2. An asterisk indicates statistically significant differences compared to
wild-type (wt) data (p , 0.0001). The shape and size of haf cells are significantly different from those of wt cells; at both LHT and expanded chamber
stages, haf cells are larger and more elongated.
(F–H) Confocal projections of live hearts, as in Figure 2, confirm the abnormal size and shape of haf mutant cardiomyocytes in the expanded ventricle.
haf cells ([G and H] arrows) are larger than their wt counterparts ([F] arrow) and can be greatly elongated (G). Size bar represents 20 lm.
doi:10.1371/journal.pbio.0050053.g007
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avoiding chamber dilation. Thus, a balance between extrinsic
and intrinsic functional inputs is important for the control of
cardiomyocyte shape and, consequently, chamber shape.
The proposed balance between the functional inputs of
ﬂow and contractility is likely to reﬂect a balance between
opposing biomechanical forces. Although our experiments
do not address the speciﬁc physical forces impacting chamber
curvature, our data are consistent with a model in which
equilibrium between ﬂuid forces and cellular tension
inﬂuences cardiomyocyte morphology. Fluid forces could
affect cardiomyocyte shape in several ways. Sensation of shear
forces by the endocardium could indirectly trigger cellular
deformation in the myocardium. Endothelial cells are known
to respond to shear forces via changes in gene expression in
vitro [34,35] and in vivo [36] and, in zebraﬁsh, shear forces are
predicted to exist at levels detectable by endocardium at 37
hpf, when chamber emergence is underway [26]. Alterna-
tively, hemodynamic pressure could play a more direct role in
stretching cardiomyocytes. We favor this idea, since the
ﬂattened, elongated, and aligned morphologies of OC cells
are reminiscent of the shapes assumed by stretched cardio-
myocytes in culture [37,38].
Although ﬂuid forces seem to encourage distortion of
cardiomyocyte dimensions, cardiomyocyte contractility pro-
vides resistance to cell shape change, perhaps by producing
inherent cellular tension. This tension could result from the
elastic nature of actively contracting sarcomeres. Alterna-
tively, sarcomere assembly could contribute to the organ-
ization of actomyosin cytoskeletal structures that create
Figure 8. Cells Lacking Vmhc Assume Different Morphologies under Different Hemodynamic Conditions
(A–D) Phalloidin staining (red) of wild-type (wt) and wea;haf double mutant hearts expressing Tg(cmlc2:egfp) at LHT (A and B) and expanded chamber (C
and D) stages. Insets highlight representative cell shapes in white. wea;haf cells are irregularly shaped and lack apparent organization or alignment.
(E) Bar graphs depict surface area and circularity measurements, as in Figure 2. An asterisk indicates statistically significant differences compared to wt
data (p , 0.0001). Despite their irregular organization and morphology, wea;haf ventricular cells exhibit a size and circularity range similar to that of wt
cells and distinct from that of wea or haf. Notably, wea;haf ventricular cells enlarge more than wea cells do (p , 0.0001), even though wea;haf mutants
lack blood flow. Also, wea;haf cell morphologies are not as extreme in size (p , 0.0001) or elongation (p , 0.001) as haf cell morphologies, even though
wea;haf mutant cells lack Vmhc.
(F–K) Chimeric ventricles resulting from transplantation of rhodamine dextran-labeled blastomeres into wt hosts expressing Tg(cmlc2:egfp). Optical
sections of (F, G, and H) are shown in (I, J, and K), respectively. (F, G, I, and J) Cells from wt or wea donors integrate normally within the wall of the wt
host ventricle. (H and K) In contrast, cells from haf donors project abnormally from the ventricular wall and fail to maintain normal shape, indicating a
cell-autonomous requirement for Vmhc in the maintenance of cardiomyocyte morphology. Size bar represents 20 lm.
doi:10.1371/journal.pbio.0050053.g008
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sarcomere integrity is critical for the maintenance of
cardiomyocyte morphology. This conclusion is compatible
with a previous study in zebraﬁsh demonstrating that trans-
planted cells lacking the giant protein Titin have difﬁculty
integrating into the wild-type chamber wall [39]. Titin is a
multidomain protein with several proposed functions [40];
our results suggest that the protrusion phenotype observed in
cells lacking Titin is related to the role of Titin in sarcomere
organization.
Although both IC and OC cells respond to functional
inputs, it is clear that they respond differently, such that
elongation occurs only in the region of the OC. We propose
that intrinsic patterning programs evident in the LHT create
differences among future IC and OC cells, perhaps conferring
differential vulnerability to functional inputs. These initial
differences could be the predecessors of the distinct
mechanical properties of each curvature, such as the greater
stiffness of the IC observed in the chick heart [41]. Our
examination of nppa expression indicates a molecular
distinction between the future IC and OC cells within the
LHT, before cell shape changes begin. This initial region-
alization of nppa expression, apparent in the LHT of wea
mutants, haf mutants, and wea;haf mutants, is evidently not
dependent on either blood ﬂow or contractility (Figure 5A–
5D). In contrast, later nppa expression in the expanded
chamber appears to relate to functional inputs, responding as
cells do to the forces promoting elongation. As stretch is a
primary inducer of nppa expression [42,43], expression of
nppa in the OC may correlate with increased levels of stretch
in those cells. Together, our data suggest a model in which
organ shape is the product of cell shape derived from the
integration of patterning programs with balanced physical
forces. The interplay between extrinsic forces and intrinsic
cellular properties has the potential to inﬂuence organ shape
acquisition even in noncontractile tissues, particularly those
that experience biomechanical inputs generated by circulat-
ing ﬂuids (e.g., kidney tubules [44] or brain ventricles [45]).
Implications for the Origins of Cardiomyopathy
Our proposed model is likely to be relevant to the
mechanisms underlying cardiomyopathy. Mutation of the
human cardiac myosin heavy chain genes MYH6 or MYH7 can
cause hypertrophic cardiomyopathy [46,47], and mutation of
MYH7 can cause dilated cardiomyopathy [38]. It is not yet
understood how the various mutations identiﬁed lead to the
diversity of phenotypes observed in patients [48]. Here, we
demonstrate two distinct cellular mechanisms by which
mutation of myosin heavy chain genes can create abnormal
ventricular morphology: a cell-autonomous mechanism via
mutation of vmhc and a cell non-autonomous mechanism via
mutation of amhc. Furthermore, our model suggests that even
subtle modiﬁcation of circulation or contractility could lead
to abnormalities in cell morphology with signiﬁcant con-
sequences for chamber morphology. Thus, our ﬁndings
broaden the array of mechanisms to consider as cellular
etiologies of cardiomyopathy.
Materials and Methods
Immunoﬂuorescence and F-actin staining. Whole-mount immu-
nostaining was performed as previously described [49], using primary
antibodies against sarcomeric myosin heavy chain (MF20) and
tropomyosin (CH1). MF20 and CH1 were obtained from the
Developmental Studies Hybridoma Bank (Iowa City, Iowa, United
States), maintained by the Department of Biological Sciences,
University of Iowa, under contract NO1-HD-2–3144 from the
National Institute of Child Health and Human Development
(NICHD). Secondary antibodies were obtained from Southern
Biotech (Birmingham, Alabama, United States). We visualized cell
outlines with rhodamine-conjugated phalloidin (Molecular Probes,
Eugene, Oregon, United States) at a dilution of 1:75, using a protocol
that preserves GFP ﬂuorescence in ﬁxed embryos [50].
In situ hybridization. Probes for cmlc2, vmhc, amhc, and nppa [28,51]
were used as previously described for standard in situ hybridization.
For ﬂuorescent in situ hybridization, probes were labeled with
digoxygenin (Roche, Basel, Switzerland), ﬂuorescein (Roche), or
dinitrophenol (Mirus, Madison, Wisconsin, United States) and were
detected by deposition of ﬂuorescein or Cy3 tyramides (PerkinElmer,
Wellesley, Massachusetts, United States). A detailed protocol for
ﬂuorescent in situ hybridization will be published separately (J.
Schoenebeck, B. Keegan, and D. Yelon, unpublished data).
Mosaic labeling of cardiomyocytes. Embryos homozygous for
Tg(cmlc2:egfp) were injected at the one-cell stage with 5 pg of
Tg(cmlc2:dsredt4) plasmid DNA. The Tg(cmlc2:dsredt4) transgene drives
expression of dsredt4 [52] with an approximately 0.8-kb fragment
found upstream of the 59 UTR of cmlc2 ( 870/þ3; [32]). Injected
embryos typically had zero to ten cardiomyocytes expressing both
dsredt4 and egfp. Embryos of interest were mounted in viewing
chambers with 0.2% tricaine to anesthetize the embryo and minimize
cardiac contraction during confocal imaging.
Imaging. Embryos were examined with Zeiss M2Bio and Axioplan
microscopes and photographed with a Zeiss Axiocam digital camera
(Carl Zeiss, Oberkochen, Germany). Images were processed using
Zeiss Axiovision and Adobe Photoshop software (Adobe Systems, San
Jose, California, United States). Live embryo videos were recorded
and processed using an Optronics DEI750 video camera, a Zeiss
M2Bio microscope, and iMovie software. Transmission electron
microscopy procedures were conducted as previously described
[28]. Confocal images were obtained using a Zeiss LSM510 confocal
laser-scanning microscope and LSM software. Z-stacks were rendered
in 3D and analyzed with Volocity software (Improvision, Coventry,
United Kingdom).
Morphometrics. We used ImageJ software (National Institutes of
Health [NIH] http://rsb.info.nih.gov/ij/) to trace cell outlines and
measure each cell’s surface area and perimeter. Cells were chosen for
measurement when their outlines were clearly visible and sharply
rendered in the xy plane of view. Circularity was calculated by ImageJ
as a normalized ratio of area (A) to perimeter (P), with a ratio of 1
representing a perfect circle (circularity ¼ 4pA/P
2). In this way, the
circularity value distinguishes cells with more circular surfaces from
those with more elliptical or elongated surfaces.
Measurements of cells from multiple embryos at the LHT stage
(24–28 hpf) and at the expanded chamber stage (48–58 hpf) were
pooled into datasets. When analyzing the LHT, we measured cells
throughout the outﬂow half of the tube, thereby including cells that
will contribute to the future ventricular IC and OC. In the expanded
wild-type ventricle (48–58 hpf), the IC and OC could easily be
distinguished morphologically. Because the curvatures were distorted
in mutant or BDM-treated embryos, we compared cardiomyocytes
throughout the mutant or BDM-treated ventricle to pooled data from
wild-type ventricular cardiomyocytes. Sample sizes were as follows:
wild-type LHT, 173 cells from 11 embryos; wild-type chamber, 336
cells from 18 embryos; wild-type IC, 122 cells from 14 embryos; wild-
type OC, 210 cells from 16 embryos; wea LHT, 99 cells from four
embryos; wea chamber, 250 cells from 17 embryos; BDM-treated
chamber, 99 cells from 14 embryos; haf LHT, 215 cells from 13
embryos; haf chamber, 149 cells from seven embryos; wea;haf LHT, 114
cells from six embryos; and wea;haf chamber, 161 cells from ten
embryos. Area and circularity values were compared using unpaired
t-tests.
Identiﬁcation of the half-hearted mutation. We isolated the half-
hearted (haf
sk24) mutation in our laboratory’s ongoing screen for
ethylnitrosourea-induced mutations that disrupt chamber form and
function (F. Olale, T. Bruno, A. Schier, and D. Yelon, unpublished
data). In this screen, we analyzed the haploid progeny of F1 females at
30–48 hpf using established protocols for live imaging and immuno-
ﬂuorescent detection of sarcomeric myosin heavy chain [49]. haf
mutants were evident during screening because of their noncon-
tractile and dysmorphic ventricles. Corresponding with the lack of
ventricular contractility, immunolocalization of sarcomeric myosin
heavy chain was absent from the haf mutant ventricle (Figure 3K), and
ultrastructural analyses via electron microscopy revealed an absence
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that the haf mutation is located near the SSLP marker Z13475 on
Chromosome 2 (one recombinant in 50 meioses), near the vmhc gene
[28]. Sequencing of genomic DNA in haf mutants identiﬁed a C to T
transition at position 3,094 of the vmhc open reading frame, creating
a premature stop codon (Figure 6C). The wild-type Vmhc protein
contains 1,937 amino acids, and the predicted haf Vmhc protein
would terminate after amino acid 1,058, disrupting the myosin tail
domain to result in a nonfunctional truncated product. Furthermore,
in situ hybridization demonstrated a marked decrease of vmhc
transcript in the haf mutant ventricle (Figure 6D and 6E), suggesting
degradation of the mutant transcript by nonsense-mediated decay.
Thus, protein production is unlikely, consistent with the loss of
detectable ventricular myosin heavy chain (Figure 3K). Taken
together, these analyses indicate that the haf locus encodes Vmhc.
Transplantation. We used standard transplantation techniques at
midblastula stages [53]. To create each chimeric embryo, we placed
10–15 blastomeres from a donor embryo near the embryonic margin
of a host embryo. For transplant hosts, we used wild-type embryos
homozygous for Tg(cmlc2:egfp). Transplant donors were generated
from intercrosses of wea or haf heterozygotes carrying Tg(cmlc2:egfp)
and injected with rhodamine dextran (Molecular Probes) as a lineage
tracer. Donor embryos were retained for retrospective identiﬁcation
as mutant or wild-type based on phenotypic analysis at 48 hpf. We
observed no differences in viability among transplanted cells for all
genotypes.
Supporting Information
Video S1. Example of an Elongated OC Cell within the Ventricle
Video shows an example of mosaically labeled egfp- and dsredt4-
expressing cardiomyocytes rendered in three dimensions and rotated
for alternate views. Video corresponds to the cell highlighted in
Figure 2F and 2J. Arrow in frame 1 points to the cell of interest. Scale
is indicated in the lower right corner.
Found at doi:10.1371/journal.pbio.0050053.sv001 (1.6 MB MOV).
Video S2. Example of a Flattened, Non-Oriented OC Cell
Video corresponds to the cell highlighted in Figure 2G and 2K.
Format as described for Video S1.
Found at doi:10.1371/journal.pbio.0050053.sv002 (7.2 MB MOV).
Video S3. Example of a Cuboidal Cell of the IC
Video corresponds to the cell highlighted in Figure 2H and 2L.
Format as described for Video S1.
Found at doi:10.1371/journal.pbio.0050053.sv003 (6.9 MB MOV).
Video S4. Wild-Type Embryo at 48 hpf Demonstrating Normal
Cardiac Chamber Contractions
Video of live wild-type 48-hpf embryo carrying Tg(cmlc2:egfp); both
chambers contract. Ventricle is to the left.
Found at doi:10.1371/journal.pbio.0050053.sv004 (5.2 MB MOV).
Video S5. Atrial Contractile Deﬁcit in wea
Video of live wea 48-hpf embryo carrying Tg(cmlc2:egfp); the ventricle
contracts and the atrium beats weakly. Ventricle is to the left.
Found at doi:10.1371/journal.pbio.0050053.sv005 (6.0 MB MOV).
Video S6. Ventricular Contractile Defect in haf
Video of live haf 48-hpf embryo carrying Tg(cmlc2:egfp); the ventricle is
noncontractile and the atrium contracts. Ventricle is to the left.
Found at doi:10.1371/journal.pbio.0050053.sv006 (7.0 MB MOV).
Video S7. The wea;haf Heart Is Noncontractile
Video of live wea;haf 48-hpf embryo carrying Tg(cmlc2:egfp); neither
chamber contracts. Ventricle is to the left.
Found at doi:10.1371/journal.pbio.0050053.sv007 (3.7 MB MOV).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
bers for the genes discussed in this paper are myh6 (NM_198823) and
vmhc (AF114427).
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